首页> 外文期刊>BMC Genomics >A novel RNAseq–assisted method for MHC class I genotyping in a non-model species applied to a lethal vaccination-induced alloimmune disease
【24h】

A novel RNAseq–assisted method for MHC class I genotyping in a non-model species applied to a lethal vaccination-induced alloimmune disease

机译:一种新型的RNAseq辅助方法,用于非模型物种中的MHC I类基因分型,适用于致死性疫苗诱导的同种免疫疾病

获取原文
           

摘要

Background MHC class I genotyping is essential for a wide range of biomedical, immunological and biodiversity applications. Whereas in human a comprehensive MHC class I allele catalogue is available, respective data in non-model species is scarce in spite of decades of research. Results Taking advantage of the new high-throughput RNA sequencing technology (RNAseq), we developed a novel RNAseq-assisted method (RAMHCIT) for MHC class I typing at nucleotide level. RAMHCIT is performed on white blood cells, which highly express MHC class I molecules enabling reliable discovery of new alleles and discrimination of closely related alleles due to the high coverage of alleles with reads. RAMHCIT is more comprehensive than previous methods, because no targeted PCR pre-amplification of MHC loci is necessary, which avoids preselection of alleles as usually encountered, when amplification with MHC class I primers is performed prior to sequencing. In addition to allele identification, RAMHCIT also enables quantification of MHC class I expression at allele level, which was remarkably consistent across individuals. Conclusions Successful application of RAMHCIT is demonstrated on a data set from cattle with different phenotype regarding a lethal, vaccination-induced alloimmune disease (bovine neonatal pancytopenia), for which MHC class I alleles had been postulated as causal agents.
机译:背景MHC I类基因分型对于广泛的生物医学,免疫学和生物多样性应用至关重要。尽管在人类中可以获得全面的MHC I类等位基因目录,但尽管进行了数十年的研究,但非模型物种的相关数据却很少。结果利用新的高通量RNA测序技术(RNAseq),我们开发了一种新颖的RNAseq辅助方法(RAMHCIT),用于在核苷酸水平上进行MHC I类分型。 RAMHCIT在白细胞上进行,白细胞高度表达MHC I类分子,能够可靠地发现新等位基因,并且由于等位基因的读取覆盖率很高,因此可以区分密切相关的等位基因。 RAMHCIT比以前的方法更全面,因为不需要MHC基因座的靶向PCR预扩增,这样可以避免在测序之前用I类MHC引物进行扩增时通常遇到的等位基因预选。除等位基因鉴定外,RAMHCIT还可以在等位基因水平上对MHC I类表达进行定量,这在个体之间非常一致。结论RAMHCIT的成功应用在具有不同表型的牛的数据集上得到了证明,该数据涉及致死性,疫苗诱导的同种免疫疾病(牛新生儿全血细胞减少症),其中MHC I类等位基因被假定为病原体。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号